Susanne Stoelben

Title: Susanne Stoelben: Innovator in Transdermal Therapeutics

Introduction

Susanne Stoelben is a notable inventor based in Cologne, Germany. She has made significant contributions to the field of transdermal therapeutic systems, particularly in the administration of memantine, a drug used for treating central nervous system disorders. Her innovative approach has the potential to enhance the delivery and efficacy of medications.

Latest Patents

Susanne Stoelben holds a patent for the transdermal administration of memantine. This invention relates to transdermal therapeutic systems (TTS) that include memantine or its physiologically compatible salts as the active ingredient. The TTSs developed by Stoelben can be produced and utilized for treating various diseases of the central nervous system, showcasing her commitment to advancing medical treatments.

Career Highlights

Throughout her career, Stoelben has worked with prominent companies in the pharmaceutical industry. Notably, she has been associated with LTS Lohmann Therapie-Systeme AG and Grünenthal GmbH. Her experience in these organizations has allowed her to refine her expertise in therapeutic systems and drug delivery methods.

Collaborations

Stoelben has collaborated with esteemed colleagues, including René Eifler and Michael Horstmann. These partnerships have contributed to her innovative work and the development of effective therapeutic solutions.

Conclusion

Susanne Stoelben's contributions to transdermal therapeutics highlight her role as a pioneering inventor in the pharmaceutical field. Her patent for the transdermal administration of memantine represents a significant advancement in treating central nervous system diseases.